ArticleTanaffos2025
Bronchoscopy Procedures Implemented During the Pandemic Period in a University Hospital.
Article in Tanaffos, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Our objective was to review the bronchoscopy procedures conducted at our hospital during the pandemic, with a focus on the potential risks of COVID-19 transmission associated with these interventions. Materials and Methods: This comprehensive study included all patients who underwent bronchoscopy in the Department of Pulmonology at Akdeniz University from March 15 to December 31, 2020. A retrospective review of medical records covered demographic information, procedure indications, urgency, procedure type, diagnostic results, and the patient's COVID-19 history. Data collection also recorded the number of personnel involved in bronchoscopy during the pandemic, along with their COVID-19 history. Results: A total of 250 bronchoscopy procedures were performed during the study period. The majority of patients were male (74.8%), with a mean age of 58 ± 13.5 years. The most common indication for bronchoscopy was lung cancer (39.2%), followed by other causes like interstitial lung diseases and sarcoidosis. No patients with a positive pre-procedural COVID-19 PCR test were included in the procedure. All patients who underwent the procedure had a negative PCR test result. No post-procedural COVID-19 cases were observed among healthcare workers or patients following the procedures. All procedures were conducted with appropriate personal protective equipment (PPE), and SARSCoV-2 RT-PCR testing was performed on 76.8% of patients before the procedure. No complications, other than minor hemorrhages, were reported. Conclusion: Bronchoscopy performed with appropriate PPE, in a negative pressure room, and with pre-procedural SARS-CoV-2 RT-PCR testing, is a safe and effective diagnostic and therapeutic procedure during the COVID-19 pandemic. The safety protocols implemented in this study successfully minimized the risk of COVID-19 transmission to healthcare workers and patients.
Indexed as
Identifiers
42027436PMC13102290What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.